1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, December 2018 (p6)

Healthcare Analysis & Statistics, December 2018 (p6)

151-180 of about 300 reports

Diabetes Management: Insulin Pumps Market

Diabetes Management: Insulin Pumps Market

  • $ 4750
  • Industry report
  • December 2018

OverviewValued at nearly $3bn in 2017, the Insulin Pumps Market is growing at nearly 10%, one of the highest growth medical device markets today.Market growth is driven by the increasing global prevalence ...

  • Industries : Medical Device, Chronic Disease, Therapy
  • Countries : World
Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

  • $ 4750
  • Industry report
  • December 2018

OverviewMarkets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This ...

  • Industries : Cardiovascular Devices
  • Countries : World, United States, Japan
Market Spotlight: Systemic Hypertension

Market Spotlight: Systemic Hypertension

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Systemic Hypertension market, comprising key marketed and pipeline drugs, clinical trials, key upcoming and regulatory events, probability of success, patent information, ...

  • Industries : Chronic Disease
  • Countries : World
Market Spotlight: Osteoarthritis and Osteoarthritis Pain

Market Spotlight: Osteoarthritis and Osteoarthritis Pain

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Osteoarthritis and Osteoarthritis Pain market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, upcoming and regulatory ...

  • Industries : Chronic Disease, Pathology
Pneumovax 23

Pneumovax 23

  • $ 10000
  • Industry report
  • December 2018

Drug OverviewPneumovax 23 is a 23-valent polysaccharide vaccine containing 23 purified capsular antigens of Streptococcus pneumoniae serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, ...

  • Industries : Therapy
  • Countries : United States
Market Spotlight: Hodgkin’s Lymphoma, Pharma Intelligence

Market Spotlight: Hodgkin’s Lymphoma, Pharma Intelligence

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Hodgkin’s Lymphoma market, comprising key marketed and pipeline drugs, clinical trials, key upcoming and regulatory events, recent events and analyst opinion, ...

  • Industries : Cancer, Pathology
  • Countries : United States, World
Major Depressive Disorder KOL Interview – UK

Major Depressive Disorder KOL Interview – UK

  • $ 599
  • Industry report
  • December 2018

OverviewA UK key opinion leader (KOL) provides insight into the critical unmet needs in the depression market, along with future trends. Key late-phase pipeline drugs for major depressive disorder and ...

  • Industries : Mental Health, Pathology
  • Countries : United Kingdom
Interventional Neurology: Carotid Artery Stents and Embolic Protection Systems

Interventional Neurology: Carotid Artery Stents and Embolic Protection Systems

  • $ 4750
  • Industry report
  • December 2018

OverviewThis medical market and technology report provides a comprehensive discussion of the global market for carotid artery stents and embolic protection systems. Geographically, markets covered by this ...

  • Industries : Cardiovascular Devices
  • Countries : World
Market Spotlight: Benign Prostatic Hyperplasia (BPH)

Market Spotlight: Benign Prostatic Hyperplasia (BPH)

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Benign Prostatic Hyperplasia market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, probability of success, patent ...

  • Industries : Pathology
  • Countries : World, United States
Market Spotlight: Peripheral T-Cell Lymphoma (PTCL), Pharma Intelligence

Market Spotlight: Peripheral T-Cell Lymphoma (PTCL), Pharma Intelligence

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Peripheral T-Cell Lymphoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, probability of success, patent information, a 10-yea ...

  • Industries : Cancer
  • Countries : World
Market Spotlight: Sarcoma, Pharma Intelligence

Market Spotlight: Sarcoma, Pharma Intelligence

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Sarcoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, patent information, probability of success, recent events ...

  • Industries : Cancer, Pathology
  • Countries : World
Market Spotlight: Amyloidosis, Pharma Intelligence

Market Spotlight: Amyloidosis, Pharma Intelligence

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the amyloidosis market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events, probability of success, ...

  • Industries : Pathology
  • Countries : United States, World
Market Spotlight: Tumor Lysis Syndrome (TLS), Pharma Intelligence

Market Spotlight: Tumor Lysis Syndrome (TLS), Pharma Intelligence

  • $ 1318
  • Industry report
  • December 2018

This Market Spotlight report covers the Tumor Lysis Syndrome (TLS) market, comprising key marketed drugs, clinical trials, patent information, and a 10-year disease incidence forecast, as well as presenting ...

  • Industries : Cancer
  • Countries : World
Interventional Neurology: Thrombectomy Systems for Ischemic Stroke

Interventional Neurology: Thrombectomy Systems for Ischemic Stroke

  • $ 4750
  • Industry report
  • December 2018

OverviewThis analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for thrombectomy systems for ischemic stroke. This market, as ...

  • Industries : General Medicine and Specialty Medicine, Chronic Disease, Pathology
  • Countries : World
Breast Cancer Diagnostic and Treatment Devices

Breast Cancer Diagnostic and Treatment Devices

  • $ 4750
  • Industry report
  • November 2018

OverviewThis analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for breast cancer diagnostic and treatment devices.The report ...

  • Industries : Diagnostic Imaging
  • Countries : World
Respiratory Care: Airway Management Accessories and Sleep Apnea Products

Respiratory Care: Airway Management Accessories and Sleep Apnea Products

  • $ 4750
  • Industry report
  • November 2018

OverviewThe two most prevalent respiratory diseases, asthma and COPD, affect more than 480 million people worldwide. This analysis includes a discussion of products, current/forecast markets, competitors, ...

  • Industries : Respiratory Device
  • Countries : World
Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – US

Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – US

  • $ 599
  • Industry report
  • November 2018

OverviewAn interview with a US key opinion leader (KOL) on seasonal influenza vaccination coverage rates and trends in main risk groups, key marketed vaccines, pipeline approaches, and the potential fo ...

  • Industries : Therapy
  • Countries : United States
Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – UK

Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – UK

  • $ 599
  • Industry report
  • November 2018

OverviewAn interview with a UK key opinion leader (KOL) on seasonal influenza vaccination coverage rates and trends in main risk groups, key marketed vaccines, pipeline approaches, and the potential fo ...

  • Industries : Therapy
  • Countries : United Kingdom
Datamonitor Healthcare Meningococcal and Pneumococcal Vaccines KOL Interview – UK

Datamonitor Healthcare Meningococcal and Pneumococcal Vaccines KOL Interview – UK

  • $ 599
  • Industry report
  • November 2018

OverviewAn interview with a UK key opinion leader (KOL) on meningococcal and pneumococcal vaccination coverage rates, vaccination rate trends in main risk groups, key marketed vaccines, pipeline approaches, ...

  • Industries : Therapy
  • Countries : United Kingdom
Datamonitor Healthcare Meningococcal and Pneumococcal Vaccines KOL Interview – US

Datamonitor Healthcare Meningococcal and Pneumococcal Vaccines KOL Interview – US

  • $ 599
  • Industry report
  • November 2018

OverviewAn interview with a US key opinion leader (KOL) on meningococcal and pneumococcal vaccination coverage rates, vaccination rate trends in main risk groups, key marketed vaccines, pipeline approaches, ...

  • Industries : Therapy
  • Countries : United States
Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Embolization Systems

Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Embolization Systems

  • $ 4750
  • Industry report
  • November 2018

OverviewThis medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and arteriovenous malformation (AVM) embolization systems. ...

  • Industries : Mental Health, Pathology
Diabetes Management: Blood Glucose Monitoring Devices Market

Diabetes Management: Blood Glucose Monitoring Devices Market

  • $ 4750
  • Industry report
  • November 2018

OverviewValued at approximately $6.6bn in 2017, the Blood Glucose Monitoring Devices market is being driven by the new and innovative continuous glucose monitoring systems (CGMs) segment, which is expanding ...

  • Industries : Patient Monitoring, Diagnostics
  • Countries : World
Diabetes Type 1 Market and Forecast Analysis to 2025

Diabetes Type 1 Market and Forecast Analysis to 2025

  • $ 22000
  • Industry report
  • October 2018

DISEASE OVERVIEWDiabetes mellitus is a group of chronic endocrine disorders characterized by hyperglycemia due to insufficient levels of insulin, a hormone responsible for regulating blood sugar. Type ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : Japan, United States, European Union
Diabetes Type 2 Market and Forecast Analysis to 2024

Diabetes Type 2 Market and Forecast Analysis to 2024

  • $ 22000
  • Industry report
  • October 2018

DISEASE OVERVIEWDiabetes occurs when the body cannot use sugars properly due to impaired insulin production or utilization. Prolonged hyperglycemia (high blood sugar) can lead to serious complications ...

  • Industries : Chronic Disease, Pathology
  • Countries : European Union, United States, Japan
Pulmonary Arterial Hypertension Market and Forecast Analysis to 2025

Pulmonary Arterial Hypertension Market and Forecast Analysis to 2025

  • $ 22000
  • Industry report
  • October 2018

Disease OverviewPulmonary arterial hypertension is one of a group of rare and life-threatening diseases collectively known as pulmonary hypertension (PH). Each PH subgroup shares similar pathophysiology, ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, European Union, Japan
Tracleer

Tracleer

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewTracleer (bosentan; Johnson and Johnson) was the first oral therapy to be developed specifically for the treatment of PH. Tracleer is a competitive endothelin receptor type A and B antagonist, ...

  • Industries : Therapy
  • Countries : United States, Japan, European Union
Revatio

Revatio

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewRevatio (sildenafil; Pfizer) is a selective inhibitor of the PDE5 enzyme, which enhances the effect of the endogenous vasodilator, nitric oxide. The extracellular vasodilator NO activates ...

  • Industries : Chronic Disease
  • Countries : United States, Japan, European Union
esuberaprost

esuberaprost

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewEsuberaprost (United Therapeutics) is an oral chemically stable prostacyclin analog targeting the prostaglandin I2 (PGI2) receptor. PGI2 agonists are potent vasodilators and platelet aggregation ...

  • Industries : Therapy
  • Countries : United States
bardoxolone methyl

bardoxolone methyl

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewBardoxolone methyl (AbbVie/Kyowa Hakko Kirin), under development by the research-stage company Reata Pharmaceuticals, is a Phase III candidate in clinical trials for the treatment of pulmonary ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Japan, European Union
Uptravi

Uptravi

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewUptravi (selexipag; Johnson and Johnson/Nippon Shinyaku) is a first-in-class oral selective non-prostanoid prostaglandin I2 (PGI2) receptor agonist. The drug and its active metabolite, ACT-333679, ...

  • Industries : Chronic Disease
  • Countries : United States, Japan, European Union
About 292000 reports

Download Unlimited Documents from Trusted Public Sources

Global Addiction Disorder Statistics

  • October 2019
    9 pages
  • Addiction Disor...  

  • World  

    Europe  

View report >

Diabetes Statistics October 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on